Jane Street’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83B | Buy |
1,994,900
+391,600
| +24% | +$397M | 0.24% | 53 |
|
|
2025
Q4 | $1.72B | Buy |
1,603,300
+106,300
| +7% | +$102M | 0.26% | 51 |
|
|
2025
Q3 | $1.14B | Buy |
1,497,000
+340,700
| +29% | +$254M | 0.17% | 79 |
|
|
2025
Q2 | $901M | Buy |
1,156,300
+326,900
| +39% | +$254M | 0.18% | 70 |
|
|
2025
Q1 | $685M | Sell |
829,400
-193,400
| -19% | -$161M | 0.17% | 69 |
|
|
2024
Q4 | $790M | Sell |
1,022,800
-24,900
| -2% | -$20.6M | 0.17% | 60 |
|
|
2024
Q3 | $928M | Sell |
1,047,700
-31,200
| -3% | -$28.1M | 0.2% | 50 |
|
|
2024
Q2 | $977M | Buy |
1,078,900
+365,900
| +51% | +$293M | 0.22% | 55 |
|
|
2024
Q1 | $555M | Buy |
713,000
+100,800
| +16% | +$71.7M | 0.12% | 88 |
|
|
2023
Q4 | $357M | Buy |
612,200
+2,100
| +0.3% | +$1.23M | 0.09% | 112 |
|
|
2023
Q3 | $328M | Buy |
610,100
+74,800
| +14% | +$38.5M | 0.11% | 90 |
|
|
2023
Q2 | $251M | Buy |
535,300
+312,000
| +140% | +$131M | 0.08% | 123 |
|
|
2023
Q1 | $76.7M | Sell |
223,300
-200
| -0.1% | -$67.5K | 0.03% | 371 |
|
|
2022
Q4 | $81.8M | Sell |
223,500
-169,700
| -43% | -$60.2M | 0.04% | 353 |
|
|
2022
Q3 | $127M | Buy |
393,200
+129,500
| +49% | +$41M | 0.06% | 212 |
|
|
2022
Q2 | $85.5M | Buy |
263,700
+76,400
| +41% | +$22.9M | 0.04% | 353 |
|
|
2022
Q1 | $53.6M | Sell |
187,300
-243,800
| -57% | -$62.7M | 0.02% | 650 |
|
|
2021
Q4 | $119M | Buy |
431,100
+132,700
| +44% | +$33.6M | 0.04% | 322 |
|
|
2021
Q3 | $68.9M | Buy |
298,400
+104,700
| +54% | +$25.8M | 0.02% | 466 |
|
|
2021
Q2 | $44.5M | Buy |
193,700
+51,300
| +36% | +$10.3M | 0.02% | 605 |
|
|
2021
Q1 | $26.6M | Buy |
142,400
+55,000
| +63% | +$10.8M | 0.01% | 777 |
|
|
2020
Q4 | $14.8M | Sell |
87,400
-84,600
| -49% | -$12.6M | 0.01% | 1096 |
|
|
2020
Q3 | $25.5M | Sell |
172,000
-257,800
| -60% | -$39.9M | 0.02% | 647 |
|
|
2020
Q2 | $70.6M | Buy |
429,800
+221,800
| +107% | +$34M | 0.05% | 251 |
|
|
2020
Q1 | $28.9M | Buy |
208,000
+147,000
| +241% | +$20.2M | 0.03% | 353 |
|
|
2019
Q4 | $8.02M | Buy |
61,000
+30,400
| +99% | +$3.52M | 0.01% | 760 |
|
|
2019
Q3 | $3.42M | Buy |
30,600
+16,500
| +117% | +$1.84M | 0.01% | 1289 |
|
|
2019
Q2 | $1.56M | Sell |
14,100
-577,100
| -98% | -$68M | ﹤0.01% | 2149 |
|
|
2019
Q1 | $76.7M | Buy |
591,200
+514,000
| +666% | +$62.5M | 0.12% | 120 |
|
|
2018
Q4 | $8.93M | Buy |
77,200
+56,200
| +268% | +$6.28M | 0.02% | 640 |
|
|
2018
Q3 | $2.25M | Buy |
21,000
+2,400
| +13% | +$240K | ﹤0.01% | 1777 |
|
|
2018
Q2 | $1.59M | Buy |
18,600
+10,400
| +127% | +$854K | ﹤0.01% | 2204 |
|
|
2018
Q1 | $634K | Sell |
8,200
-14,400
| -64% | -$1.16M | ﹤0.01% | 3194 |
|
|
2017
Q4 | $1.91M | Buy |
+22,600
| New | +$1.92M | 0.01% | 1643 |
|
|
2017
Q3 | – | Sell |
-5,600
| Closed | -$461K | – | 4810 |
|
|
2017
Q2 | $461K | Sell |
5,600
-48,700
| -90% | -$3.97M | ﹤0.01% | 3128 |
|
|
2017
Q1 | $4.57M | Sell |
54,300
-39,700
| -42% | -$3.18M | 0.02% | 762 |
|
|
2016
Q4 | $6.91M | Sell |
94,000
-35,800
| -28% | -$2.67M | 0.03% | 507 |
|
|
2016
Q3 | $10.4M | Buy |
129,800
+124,500
| +2,349% | +$9.97M | 0.05% | 300 |
|
|
2016
Q2 | $417K | Buy |
5,300
+600
| +13% | +$45.2K | ﹤0.01% | 2946 |
|
|
2016
Q1 | $338K | Buy |
+4,700
| New | +$356K | ﹤0.01% | 3074 |
|
|
2015
Q3 | – | Sell |
-5,200
| Closed | -$434K | – | 3911 |
|
|
2015
Q2 | $434K | Buy |
+5,200
| New | +$396K | ﹤0.01% | 2438 |
|
|
2015
Q1 | – | Sell |
-6,800
| Closed | -$469K | – | 3339 |
|
|
2014
Q4 | $469K | Buy |
+6,800
| New | +$459K | ﹤0.01% | 1532 |
|
Other funds holding LLY
VCM
VPM
Jane Street's LLY Position: Q1 2026 in Review
Jane Street reduced its Eli Lilly (LLY) stake by 55% in Q1 2026, selling an estimated $141M and leaving 115,863 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #613.
Jane Street first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $488M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Jane Street held 115,863 shares of Eli Lilly worth $107M as of Q1 2026.
- Jane Street sold 139,261 Eli Lilly shares in Q1 2026, an estimated $141M.
- Eli Lilly made up 0.01% of Jane Street's portfolio in Q1 2026, its #613 holding.
- Jane Street first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Eli Lilly position peaked at $488M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.